Treatment of Borrmann Type IV Gastric Cancer with a Neoadjuvant Chemotherapy Combination of Docetaxel, Cisplatin and 5-Fluorouracil/Leucovorin

By Sun X-C   Lin J   Ju A-H  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2096-2102

Field House Publishing

Access to resources Recommend Favorite

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

By Boku Narikazu   Muro Kei   Machida Nozomu   Hashigaki Satoshi   Kimura Nobuyuki   Suzuki Mie   Lechuga Mariajose   Miyata Yoshinori  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study

By Morgan Robert  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 723-728

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

By Kumar Aalok   Kennecke Hagen F.   Renouf Daniel J.   Lim Howard J.   Gill Sharlene   Woods Ryan   Speers Caroline   Cheung Winson Y.  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 527-534

Blackwell Publishing

Access to resources Recommend Favorite

Adjuvant chemotherapy in patients with clinically well advanced prostate cancer (stage T3) after surgery `cannot be recommended'

By  

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite